Young-A Heo
- Mirvetuximab Soravtansine: First Approval
2023/01/19 by Young-A Heo, Young‐A Heo · 25 citations
Medicine · #Advanced Breast Cancer Therapies #Antibody #Antibody therapy #Antibody-drug conjugate #Cancer #Conjugate #Drug holiday #Fallopian tube #Gynecology #Immunogen #Immunology #Internal medicine #Medicine #Monoclonal antibody #Oncology #Ovarian cancer #Ovarian cancer diagnosis and treatment #PARP inhibition in cancer therapy #Pharmacology